MENU
LENZ
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
LENZ Therapeutics (LENZ) Ownership - Who owns LENZ Therapeutics?
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products... Show more
Profile
Industry
N/A
Address
445 Marine View Avenue
Phone
+1 858 925-7000
Employees
N/A
Web
https://www.lenz-tx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.08B
P/E Ratio
48.03
Total Cash
209.52M
Projected Growth
N/A
Total Debt
1.05M
Revenue
5M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
7.35
Total Debt/Equity
N/A
Revenue/Share
0.18 USD as % of share price
Fundamentals
LENZ
Capitalization
1.08B
P/E Ratio
48.03
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
210M
Total Cash/Share
7.35
Total Debt
1.05M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.18%
Revenue
5M
ROE
N/A
Book Value
206M
P/B Ratio
5.23
Cash Flow
N/A
Earnings
-1.63
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
20.54
Current Revenue Per Employee
119047.62
Dividends Per Share - Security
N/A
EBITDA
-61.87M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-24.95
Shares Held By Institutions
1.84B
Shares Outstanding - Current
28.5M
Total Liabilities
11M
Total Volume MTD
N/A
Value
-1
Gain YTD
31.105
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
445 Marine View Avenue
Phone
+1 858 925-7000
Employees
N/A
Web
https://www.lenz-tx.com